These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29906748)

  • 41. Role of cationic channel TRPV2 in promoting prostate cancer migration and progression to androgen resistance.
    Monet M; Lehen'kyi V; Gackiere F; Firlej V; Vandenberghe M; Roudbaraki M; Gkika D; Pourtier A; Bidaux G; Slomianny C; Delcourt P; Rassendren F; Bergerat JP; Ceraline J; Cabon F; Humez S; Prevarskaya N
    Cancer Res; 2010 Feb; 70(3):1225-35. PubMed ID: 20103638
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 8-bromo-5-hydroxy-7-methoxychrysin targeting for inhibition of the properties of liver cancer stem cells by modulation of Twist signaling.
    Ren KQ; Cao XZ; Liu ZH; Guo H; Quan MF; Liu F; Jiang L; Xiang HL; Deng XY; Cao JG
    Int J Oncol; 2013 Nov; 43(5):1719-29. PubMed ID: 23970349
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD133
    Liu K; Hao M; Ouyang Y; Zheng J; Chen D
    Sci Rep; 2017 Jan; 7():41499. PubMed ID: 28134312
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells.
    Wang R; Sun Q; Wang P; Liu M; Xiong S; Luo J; Huang H; Du Q; Geller DA; Cheng B
    Oncotarget; 2016 Feb; 7(5):5754-68. PubMed ID: 26735577
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Musashi 2 contributes to the stemness and chemoresistance of liver cancer stem cells via LIN28A activation.
    Fang T; Lv H; Wu F; Wang C; Li T; Lv G; Tang L; Guo L; Tang S; Cao D; Wu M; Yang W; Wang H
    Cancer Lett; 2017 Jan; 384():50-59. PubMed ID: 27721018
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Functional TRPV2 and TRPV4 channels in human cardiac c-kit(+) progenitor cells.
    Che H; Xiao GS; Sun HY; Wang Y; Li GR
    J Cell Mol Med; 2016 Jun; 20(6):1118-27. PubMed ID: 26865051
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Arsenite inhibits the function of CD133
    Tang H; Jin Y; Jin S; Tan Z; Peng Z; Kuang Y
    Tumour Biol; 2016 Oct; 37(10):14103-14115. PubMed ID: 27517564
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF-κB-HIF-1α pathway.
    Cao L; Fan X; Jing W; Liang Y; Chen R; Liu Y; Zhu M; Jia R; Wang H; Zhang X; Zhang Y; Zhou X; Zhao J; Guo Y
    Oncotarget; 2015 Mar; 6(9):6627-40. PubMed ID: 25749383
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4.
    Zhou JN; Zeng Q; Wang HY; Zhang B; Li ST; Nan X; Cao N; Fu CJ; Yan XL; Jia YL; Wang JX; Zhao AH; Li ZW; Li YH; Xie XY; Zhang XM; Dong Y; Xu YC; He LJ; Yue W; Pei XT
    Hepatology; 2015 Sep; 62(3):801-15. PubMed ID: 25953743
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SENP1 promotes hypoxia-induced cancer stemness by HIF-1α deSUMOylation and SENP1/HIF-1α positive feedback loop.
    Cui CP; Wong CC; Kai AK; Ho DW; Lau EY; Tsui YM; Chan LK; Cheung TT; Chok KS; Chan ACY; Lo RC; Lee JM; Lee TK; Ng IOL
    Gut; 2017 Dec; 66(12):2149-2159. PubMed ID: 28258134
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Lipidomic Signature Complements Stemness Features Acquisition in Liver Cancer Cells.
    Rivas Serna IM; Romito I; Maugeri A; Lo Re O; Giallongo S; Mazzoccoli G; Oben JA; Li Volti G; Mazza T; Alisi A; Vinciguerra M
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182805
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of Lefty in the anti tumor activity of human adult liver stem cells.
    Cavallari C; Fonsato V; Herrera MB; Bruno S; Tetta C; Camussi G
    Oncogene; 2013 Feb; 32(7):819-26. PubMed ID: 22469982
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MK2206 overcomes the resistance of human liver cancer stem cells to sorafenib by inhibition of pAkt and upregulation of pERK.
    Zhai B; Zhang X; Sun B; Cao L; Zhao L; Li J; Ge N; Chen L; Qian H; Yin Z
    Tumour Biol; 2016 Jun; 37(6):8047-55. PubMed ID: 26711788
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence regarding a stem cell origin of hepatocellular carcinoma.
    Shupe T; Petersen BE
    Stem Cell Rev; 2005; 1(3):261-4. PubMed ID: 17142863
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stress Conditions Induced by Locoregional Therapies Stimulate Enrichment and Proliferation of Liver Cancer Stem Cells.
    Huo Y; Chen WS; Lee J; Feng GS; Newton IG
    J Vasc Interv Radiol; 2019 Dec; 30(12):2016-2025.e5. PubMed ID: 31208945
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Generation and characterization of hepatocellular carcinoma cell lines with enhanced cancer stem cell potential.
    Muenzner JK; Kunze P; Lindner P; Polaschek S; Menke K; Eckstein M; Geppert CI; Chanvorachote P; Baeuerle T; Hartmann A; Schneider-Stock R
    J Cell Mol Med; 2018 Dec; 22(12):6238-6248. PubMed ID: 30280520
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Keratin 19, a Cancer Stem Cell Marker in Human Hepatocellular Carcinoma.
    Kawai T; Yasuchika K; Ishii T; Katayama H; Yoshitoshi EY; Ogiso S; Kita S; Yasuda K; Fukumitsu K; Mizumoto M; Hatano E; Uemoto S
    Clin Cancer Res; 2015 Jul; 21(13):3081-91. PubMed ID: 25820415
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Targeting Liver Cancer and Associated Pathologies in Mice with a Mitochondrial VDAC1-Based Peptide.
    Pittala S; Krelin Y; Shoshan-Barmatz V
    Neoplasia; 2018 Jun; 20(6):594-609. PubMed ID: 29747160
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Active glycolytic metabolism in CD133(+) hepatocellular cancer stem cells: regulation by MIR-122.
    Song K; Kwon H; Han C; Zhang J; Dash S; Lim K; Wu T
    Oncotarget; 2015 Dec; 6(38):40822-35. PubMed ID: 26506419
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synergistic inhibition of characteristics of liver cancer stem-like cells with a combination of sorafenib and 8-bromo-7-methoxychrysin in SMMC-7721 cell line.
    Zou H; Cao X; Xiao Q; Sheng X; Ren K; Quan M; Song Z; Li D; Zheng Y; Zeng W; Cao J; Peng Y
    Oncol Rep; 2016 Sep; 36(3):1731-8. PubMed ID: 27461522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.